GLP-1 RAs utilize a multimechanistic approach to target not only hyperglycemia but also obesity and cardiovascular risk factors, which is contradictory to the rationale of the obesity paradox. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.